Attached files
| file | filename |
|---|---|
| EX-10.5B - EX-10.5B - BELLICUM PHARMACEUTICALS, INC | exhibit105b_2019equityince.htm |
| EX-31.1 - EX-31.1 - BELLICUM PHARMACEUTICALS, INC | exh311certofceocfo2020q4.htm |
| EX-23 - EX-23 - BELLICUM PHARMACEUTICALS, INC | bellicum-ex231consentofey2.htm |
| EX-21 - EX-21 - BELLICUM PHARMACEUTICALS, INC | bellicum-ex211subsidiaries.htm |
| 10-K - 10-K - BELLICUM PHARMACEUTICALS, INC | blcm-20201231.htm |
Exhibit 32
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Richard A. Fair, principal executive officer and principal officer of Bellicum Pharmaceuticals, Inc. (the “Registrant”), do hereby certify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based upon my knowledge:
(1)this Annual Report on Form 10-K for the fiscal year ended December 31, 2020 of the Registrant, to which this certification is attached as an exhibit (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)); and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| Date: March 30, 2021 | /s/ Richard A. Fair | ||||
| Richard A. Fair | |||||
| President and Chief Executive Officer | |||||
This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.